175 related articles for article (PubMed ID: 1354916)
1. "Peripheral" benzodiazepine recognition sites may be involved in the rapid tolerance to the sedative effects of benzodiazepines in rats.
Ambrosio C; De Luca C; Massotti M
Adv Biochem Psychopharmacol; 1992; 47():223-7. PubMed ID: 1354916
[No Abstract] [Full Text] [Related]
2. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine, barbiturate, ethanol and hypnotic steroid hormone modulation of GABA-mediated chloride ion transport in rat brain synaptoneurosomes.
Morrow AL; Suzdak PD; Paul SM
Adv Biochem Psychopharmacol; 1988; 45():247-61. PubMed ID: 2902744
[No Abstract] [Full Text] [Related]
4. Designer genes and anti-anxiety drugs.
Tecott LH
Nat Neurosci; 2000 Jun; 3(6):529-30. PubMed ID: 10816304
[No Abstract] [Full Text] [Related]
5. Development of differential tolerance to the sedative and anti-stress effects of benzodiazepines.
Mediratta PK; Sharma KK; Rana J
Indian J Physiol Pharmacol; 2001 Jan; 45(1):111-5. PubMed ID: 11211563
[TBL] [Abstract][Full Text] [Related]
6. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
7. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM
Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327
[No Abstract] [Full Text] [Related]
8. [Recent progress in the pharmacology of hypnotics and anxiolytics].
Scuvée-Moreau J; Seutin V
Rev Med Liege; 2001 Mar; 56(3):159-64. PubMed ID: 11338787
[TBL] [Abstract][Full Text] [Related]
9. GABA-benzodiazepine receptors.
Wamsley JK
Am J Psychiatry; 1992 Apr; 149(4):582-3. PubMed ID: 1348164
[No Abstract] [Full Text] [Related]
10. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change.
Gallager DW; Primus RJ
Biochem Soc Symp; 1993; 59():135-51. PubMed ID: 7910740
[No Abstract] [Full Text] [Related]
12. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
[TBL] [Abstract][Full Text] [Related]
13. Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance.
Tietz EI; Zeng XJ; Chen S; Lilly SM; Rosenberg HC; Kometiani P
J Pharmacol Exp Ther; 1999 Dec; 291(3):932-42. PubMed ID: 10565808
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to a new class of non-benzodiazepine anxiolytics.
Chodera A; Nowakowska E; Bartczak G
Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
[TBL] [Abstract][Full Text] [Related]
15. Relative affinity of quazepam for type-1 benzodiazepine receptors in brain.
Wamsley JK; Hunt MA
J Clin Psychiatry; 1991 Sep; 52 Suppl():15-20. PubMed ID: 1680119
[TBL] [Abstract][Full Text] [Related]
16. The biological basis of benzodiazepine actions.
Haefely W
J Psychoactive Drugs; 1983; 15(1-2):19-39. PubMed ID: 6136567
[No Abstract] [Full Text] [Related]
17. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
[TBL] [Abstract][Full Text] [Related]
18. CNS 7056: a novel ultra-short-acting Benzodiazepine.
Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
[TBL] [Abstract][Full Text] [Related]
19. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Wafford KA; Bain CJ; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Aug; 44(2):437-42. PubMed ID: 8102787
[TBL] [Abstract][Full Text] [Related]
20. The present status of benzodiazepines in psychopharmacology.
Iversen LL
Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
